Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as …
-
-
The Hartford appointed Annette Rippert to the company’s board of directors, effective Feb. 18, 2025. She will serve on the board’s Finance, Investment and Risk Management Committee. “Annette’s visionary leadership in …
-
HSBC announced that Lisa McGeough has officially been appointed President and Chief Executive Officer for the United States, effective January 1, 2025. In this role, Lisa will lead the next …
-
JPMorganChase announced that Michele G. Buck, 63, has been elected as a director of the company, effective March 17, 2025. Ms. Buck is Chairman of the Board, President and CEO …
-
Principal Financial Group® has announced that the Board of Directors has appointed president and chief operating officer Deanna Strable as the company’s next president and chief executive officer, effective January …